Patent · US Active

Pyrrolidine GPR40 modulators

US9714231B2 · kind B2 · utility

3Cited by

2References

15Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Bruce A. Ellsworth · Princeton, US
Elizabeth A. Jurica · Lawrence, US
Jun Shi · San Diego, US
William R. Ewing · Yardley, US
Xiang-Yang Ye · Princeton, US
Ximao Wu · Princeton Junction, US
Zhu Yeheng · Stockton, US
Sun Chongqing · Plainsboro, US

Key dates

Filing date	Nov 15, 2013
Grant date	Jul 25, 2017
Priority date	—
Expiry date	Jan 26, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are GPR40 G protein-coupled receptor modulators which may be used as medicaments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.